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Table 1. Multivariate logistic regression of concurrent apical suspension at the time of hysterectomy*
Adjusted Odds
Ratio

95% Confidence
Adjusted Odds
P value
Interval
Ratio

Any hysterectomy (N=34,123), Concurrent
apical prolapse repair

32 Non-white women are less likely to have apical
suspension at the time of hysterectomy after
controlling for geographic variations in a nationally
representative cross-sectional study using HCUP

95% Confidence
Interval

P
value

Vaginal hysterectomy (N=2,353),
Concurrent apical prolapse repair

White

1 (reference)

Black

0.58

0.51-0.67

<0.001

0.60

0.42-0.86

0.006

Hispanic

1.14

1.00-1.30

0.042

0.73

0.57-0.94

0.015

0.64

0.50-0.82

<0.001

0.48

0.29-0.81

0.006

Asian

1 (reference)

Native
American

0.66

0.29-1.51

0.328

0.33

0.04-2.83

0.310

Other race

1.31

1.07-1.60

0.007

1.23

0.81-1.88

0.331

*Adjusted for age, mortality risk, morbidity risk, median household income, hospital bed size, teaching
status, hospital ownership, payer source, metropolitan area, and geographic region

R. Wang, E. Tunitsky
Hartford Hospital, Hartford, CT

OBJECTIVES: To evaluate the differences in concurrent apical prolapse

repair at the time of hysterectomy among racial groups using a
nationally representative sample inclusive of all payers and patient
encounters that accounts for geographic differences.
MATERIALS AND METHODS: This cross-sectional study uses the HCUP
National Inpatient Sample, a national database of inpatient encounters
that includes all payers and a representative sample within the United
States. Race and ethnicity are patient reported. Hysterectomies and
apical prolapse repair procedures are identiﬁed using procedural codes.
Differences in concurrent apical prolapse repair with hysterectomy are
analyzed by racial groups and adjusted for potential confounders.
RESULTS: In 2017, 35,865 women underwent hysterectomy in this
nationally representative sample, with 18,943 (55%) White, 7,472
(22%) Black, 5,244 (15%) Hispanic, 1,472 (4.2%) Asian, 165 (0.5%)
Native American, and 1,390 (4.0%) other races. A total of 2,395 (6.9%)
of women underwent concurrent apical prolapse repair at the time of
hysterectomy, with Black and Native American women having the
lowest rates (3.6% and 3.8% respectively) (P<0.001) (Figure 1). Among
women with vaginal hysterectomies, 827 (35%) had concurrent apical
repair, with the lowest rate among Native American and Black women
(12% and 37% respectively) (P<0.001) (Figure 1). In multivariate regressions, Black (OR 0.60, 0.42-0.86, P¼0.006), Hispanic (OR 0.73,
0.57-0.94, P¼0.015), and Asian race (OR 0.48, 0.29-0.81, P¼0.006)
were signiﬁcant predictors of lower rate of concurrent apical repair with
vaginal hysterectomy after adjusting for patient, hospital, community,
payer, and geographic factors (Table 1). Similar results were obtained
for concurrent apical repair with any hysterectomy (Table 1).
CONCLUSION: A small minority of patients undergo concurrent apical
prolapse repair with hysterectomy. In this nationally representative
sample controlling for not only patient characteristics, but also potential biases in practice patterns across geographic areas, payers, and
hospital factors, Black, Hispanic, and Asian races remained signiﬁcant predictors of lower rate of concurrent apical suspension.
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OBJECTIVES: Pelvic ﬂoor disorders (PFD) affect the quality of life for
many women and can be a signiﬁcant cause of distress. With the
United States’ aging population, PFD are becoming increasingly
prevalent. Previous population based studies identiﬁed both differences in prevalence and baseline knowledge of PFD by race and
ethnicity. These prior studies assessing PFD knowledge were limited
to single geographical areas or institutions. We aim to conduct a
multicenter study across the United States to better understand the
baseline knowledge and perceptions of PFD and its variance across
different races and ethnicities. Our goal is to provide data that will
help deliver culturally competent information to patients.
MATERIALS AND METHODS: This was a multicenter cross-sectional
study involving six sites. Upon initial presentation to a urogynecology clinic, patients were evaluated with the Prolapse and Incontinence Knowledge Questionnaire along with additional questions
aimed to assess differences in PFD descriptive language, barriers to
care, and attitude towards PFD. Surveys were distributed at
participating institutions from October 2019 to February 2021.
Statistical analyses were performed with Fisher’s exact test and Chisquare test, using p <0.05 for statistical signiﬁcance.
RESULTS: A total of 287 women completed the survey, with 27
excluded due to omission of race and or ethnicity responses. Respondents identiﬁed their ethnicity as Hispanic (21.8%) and race as
White (70.5%), African American (AA) (19.2%), and Other Women
of Color (OWOC) (10.3%). Overall, the mean percent correct for
the urinary incontinence (UI) and pelvic organ prolapse (POP) subscores were 61.2  28.2 and 60.5  28.2, respectively. AA and
OWOC had lower scores compared to White respondents in both UI
(AA 60.7  30.1; OWOC 46.8  31.2; W 63.5  26.5; p ¼ 0.018)
and POP (AA 55.5 30.1; OWOC 48.9  31.0; W 64  26.2; p ¼
0.011). Hispanic women scored lower in both UI (43.9  29.8 vs
66.5  25.3, p <0.001) and POP (46.2  28.4 vs 66.5  25.3,
p<0.001) when compared to non-Hispanic respondents. AA and
OWOC had decreased knowledge of POP language compared to
White respondents (32.3  30.8 % correct vs 35.4  33.6 % correct
vs 50.4  32.9 % correct, p <0.001). This was similar for Hispanic
compared to non-Hispanic respondents (33.3  31.2 % correct vs
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40.1  32.5 % correct, p<0.001). Responses to UI and POP
misconception questions were not different by race or ethnicity.
CONCLUSION: This is the ﬁrst multicenter, cross-sectional survey of a
diverse patient population assessing knowledge and perception of
PFD. We observed differences between baseline knowledge and
language proﬁciency of PFD amongst AA, White, and OWOC, as
well as between Hispanic and non-Hispanic women. This suggests
the presence of racial disparities in women pursuing urogynecologic
care and highlights the importance of delivering culturally sensitive
information to educate women of diverse backgrounds.
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associated with a signiﬁcant increase in postoperative narcotic use
(9.66 vs. 5.59; p¼0.018). There were no statistical differences in
number of pills taken by preoperative pain score categories, longer
operative time, presence of deep endometriosis, or pathology
conﬁrmed endometriosis (all p> 0.37).
CONCLUSION: Most patients undergoing laparoscopic surgery for
endometriosis and CPP had a lower postoperative opioid requirement than prescribed. Average opioid use in our cohort is similar to
trends reported for minimally invasive surgery for non-chronic pain
indications, suggesting surgeons do not need to prescribe more
postoperative narcotics for a majority of pelvic pain patients. Patients
with long-standing CPP syndrome or mood disorders may represent
a population requiring additional postoperative opioid requirements. Larger multi-center trials are needed to better characterize trends in this population.
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OBJECTIVES: To measure postoperative opioid use following laparoscopic surgery for endometriosis and chronic pelvic pain (CPP) and
identify patient characteristics associated with greater postoperative
opioid medication requirements.
MATERIALS AND METHODS: This was a prospective, survey-based study
of 100 women undergoing laparoscopic surgery for endometriosis or
CPP by fellowship-trained, minimally invasive gynecologic surgeons
at a tertiary care academic center. Following consent, patients
completed a preoperative survey inquiring about current pain,
anticipated postoperative pain, and recent pain medication use.
Subjects completed seven surveys within 30 days postoperatively
regarding the quantity and type of pain medication used and current
pain levels. Baseline demographics, medical history, and perioperative care details were abstracted from the medical records.
Descriptive statistics were calculated for opioid pill usage. Bivariate
analyses were performed to compare opioid use at postoperative day
28 across patient and surgical characteristics via Wilcoxon rank sum
tests.
RESULTS: 100 patients were recruited, and 8 patients were excluded
for receiving additional narcotics from outside sources, for a ﬁnal
sample size of 92 patients. All patients responded to the pre-operative survey with postoperative survey response rates ranging from
72% (days 4, 14, and 28) to 80% (day 3). The average number of
pain pills prescribed to patients was 10.5, with a minimum of 4 pills
(n¼1) and maximum of 20 (n¼4). Patients reported a cumulative
277.5 opioid pills remaining at the day 28 survey, with a mean of 4.3.
34% (n¼22) of patients had no pills left, and 35% (n¼23) had at
least 7 pills remaining. The mean number of pills taken by day 1 was
1.8, by day 2 was 3.1, by day 3 was 4.5, by day 4 was 4.7, by day 7 was
6.7, and by day 28 was 6.8 (Figure 1).
There was a trend of greater opioid use in patients with preoperative diagnoses of CPP and mood disorders (7.93 vs. 5.96;
p¼0.079; 7.79 vs. 5.25; p¼0.19). Undergoing a hysterectomy was
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OBJECTIVES: Early discontinuation and non-publication are common
issues in clinical research. To promote transparency and accountability, ClinicalTrials.gov was released in the early 2000s as an open
access registry, mandating public availability of trial outcomes.
Among studies registered in ClinicalTrials.gov under ‘hysterectomy’,
we sought to ascertain time to study completion and publication,
and to determine what factors are associated with a higher likelihood
of publication.
MATERIALS AND METHODS: A query to the ClinicalTrials.gov database
with the search term ‘hysterectomy’ was performed from 1/1/2003
through 3/5/2020. Publicly available information included investigators, study title, type of research, start and completion dates,
funding entity, and country of study. All studies were searched on
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